EpirubicinAntibiotics, AntineoplasticAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideFluorouracilBreast NeoplasmsDrug Administration SchedulePaclitaxelTaxoidsTreatment OutcomeRazoxaneChemotherapy, AdjuvantCisplatinDoxorubicinDeoxycytidineDose-Response Relationship, DrugDisease-Free SurvivalInfusions, IntravenousNeoadjuvant TherapyGranulocyte Colony-Stimulating FactorVinblastineAnthracyclinesToxicity TestsSurvival AnalysisMethotrexateSurvival RateAlopeciaAntineoplastic AgentsNeutropeniaHematologic DiseasesIfosfamideLeukopeniaNeoplasm MetastasisProlyl HydroxylasesNeoplasm StagingCombined Modality TherapyNauseaStomach NeoplasmsMaximum Tolerated DoseVomitingAdenocarcinomaCarboplatinEtoposideNaphthacenesStomatitisTime FactorsAntineoplastic Agents, PhytogenicReceptor, erbB-2Drug EvaluationToxicity Tests, AcuteFollow-Up StudiesDrug Resistance, Neoplasm